Eunomia perspective · 2026-04-01 · Compliance Programmes, Audits & Training

Scalable Compliance Models for Growing Pharma in the Age of AI

Published by Eunomia Pharma Services · Updated 1 October 2026

How can a growing pharma company scale compliance?

A growing pharma company can combine advisory support for defined questions, projects for specific changes, shared services for recurring work and centralised processes across markets. Choose the model around workload, local requirements and retained decision-making. Delegating work does not automatically transfer the company’s legal obligations or oversight responsibilities. Define human review and exception routes before introducing automation.

Choosing the right model

List the activities, markets and volumes your compliance function handles today.
Decide which decisions you must keep in-house and which work can be delegated.
Start with the model that fits now, with a defined route to expand.
Assess any AI use case for governance and human oversight before scaling it.

The practical steps above are Eunomia’s operational guidance. See the source notes below for the scope of the external references.

As pharmaceutical companies scale in today’s AI-driven environment, one foundational element often lags behind: compliance infrastructure. For emerging biotechs and mid-sized pharma navigating rapid market expansion, shifting regulations, and digital transformation, a flexible, scalable compliance model is no longer a luxury—it's essential.

At Eunomia Pharma Services, we recognise that growth and governance must evolve in tandem. Our modular service architecture—ranging from Advisory Services to Shared Services, Outsourcing, and Centralisation—has been purpose-built to support compliance agility, depth, and audit readiness at every stage of the growth curve.

Why Scalability Matters in Compliance

Growth in pharma often brings complexity: new geographies, new stakeholders, new risk profiles. Traditional compliance models, rigid and siloed, struggle to keep pace. Scalable compliance, by contrast, is right-sized to current needs but capable of expanding swiftly—across languages, jurisdictions, and processes.

AI adds both urgency and opportunity. Whether it's automating HCP engagement workflows, enhancing due diligence checks, or using predictive analytics in pharmacovigilance, AI adoption must sit on a strong ethical and regulatory backbone. That’s where scalable compliance becomes the enabler, not the bottleneck.

Eunomia’s Four-Tier Model for Scalable Compliance

Advisory Services
For fast-moving companies requiring ad-hoc regulatory guidance or strategic input on internal controls, audits, or code interpretations, Eunomia offers on-demand access to senior compliance business partners across EU5. This is ideal for teams who want expert input without committing to full-time structures. Services are available in English, Spanish, French, German, and Italian.
Outsourcing
Growing pharma often faces bandwidth issues or lack of in-house compliance expertise. Eunomia fills this gap with a fully managed service model where we take end-to-end accountability. Our operational teams, backed by senior compliance partners, ensure not just delivery but audit readiness and alignment with both local and global codes.
Shared Services
A hybrid model designed for companies that want to retain ownership of their compliance framework but need reliable operational execution. Eunomia provides support through experienced professionals who are already embedded in similar client environments, creating both efficiency and best practice sharing. The model supports scalability without sacrificing control.
Centralisation
For companies expanding across Europe or centralising operations, Eunomia offers embedded country-level expertise aligned with the client's strategic direction. We can manage specific projects end-to-end or function as an extension of the client’s team—on-site or remote. This is especially useful for building consistent standards across multiple geographies.

Future-Proofing Compliance in the AI Era

The integration of AI in pharma compliance is inevitable—and powerful. But algorithms are only as ethical as the frameworks governing their use. With evolving expectations from regulators, patient groups, and industry bodies, scalable compliance must be proactive, tech-enabled, and human-guided.

Eunomia helps clients build this balance—with scalable models that grow alongside your business, adapt to new tools like AI, and ensure ethical conduct remains embedded at every level.

Let your growth be fearless. Let compliance be your strength.

Which compliance delivery model fits your workload?

Choose a delivery model by the work to be done, the decisions retained internally and the consistency needed across markets. The options can be combined. Outsourcing execution does not automatically transfer statutory accountability or the company’s responsibility for oversight.

Practical comparison: Which compliance delivery model fits your workload
Model	Useful starting situation	Define before engagement
Advisory	A team needs help with a specific question.	Decision owner, question, evidence and written output.
Project	A defined change needs delivery.	Scope, milestones, acceptance criteria and handover.
Shared service	Recurring operational work needs capacity.	Volumes, responsibilities, escalation and quality checks.
Centralised process	Several markets need a common workflow.	Global standard, local exceptions and country ownership.

What should be agreed before adding automation?

Start with a process whose inputs, decisions and exceptions are understood. Define the permitted task, access controls, validation approach and human decision points. Trial a representative set of cases, including incomplete requests and exceptions, before expanding the workflow. Measure rework, unresolved exceptions and quality alongside speed. If a system cannot explain why an item was routed or changed, faster processing may make oversight harder. Agree who maintains the workflow after handover and who approves changes.

Explore compliance workflow automation.

Sources and scope

Ministry of Justice: Bribery Act 2010 guidance
UK guidance on adequate procedures to prevent bribery; it is not a healthcare-specific checklist.
Regulation (EU) 2024/1689 (EU AI Act)
The EU regulation on artificial intelligence; how it applies depends on the AI system and its use.

External sources accessed 29 September 2026. Check the applicable country rules and current source text for a specific engagement.